A Phase 2 Open Label Study of BA3021 in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck

Clinical trial NCT05271604 · COMPLETED

Trial details

NCT number: NCT05271604
Sponsor: BioAtla, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Head and Neck Cancer Squamous Cell Carcinoma of Head and Neck Recurrent Squamous Cell Carcinoma of the Head and Neck Metastatic Cancer Metastatic Squamous Cell Carcinoma of the Head and Neck

Start date: 2022-12-13
Primary completion: 2025-09-22
Enrollment: 42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.